PBM — Psyence Biomedical Balance Sheet
0.000.00%
Last trade - 00:00- $0.23m
- -$0.50m
Annual balance sheet for Psyence Biomedical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | Final | Final | Final |
| Cash | ||||
| Cash and Short Term Investments | 1.75 | 1.33 | 0.733 | 6.14 |
| Net Total Receivables | 0.039 | 0.149 | 0.042 | 0.137 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 1.83 | 1.59 | 1.13 | 6.56 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | — | 0 | 0.005 | 0.011 |
| Long Term Investments | ||||
| Total Assets | 1.83 | 1.59 | 1.13 | 7.32 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.132 | 1.79 | 12.1 | 0.594 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Liabilities | 0.132 | 1.79 | 12.1 | 0.594 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 1.7 | -0.2 | -11 | 6.72 |
| Total Liabilities & Shareholders' Equity | 1.83 | 1.59 | 1.13 | 7.32 |
| Total Common Shares Outstanding |